# Frédéric Charlotte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/frederic-charlotte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,827 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 86 |
| i10-index | 238 |
| Last Known Institution | Sorbonne Université |
| OpenAlex ID | https://openalex.org/A5041168553 |
| ORCID iD | 0000-0003-2803-6606 |
| Works | 494 |

## Researcher papers

Showing 12 of 13.

- [Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease](https://scholariq.org/papers/sampling-variability-of-liver-biopsy-in-nonalcoholic-fatty-liver-disease/)
- [Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages](https://scholariq.org/papers/revised-classification-of-histiocytoses-and-neoplasms-of-the-macrophage/)
- [Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study](https://scholariq.org/papers/biochemical-markers-of-liver-fibrosis-in-patients-with-hepatitis-c-virus/)
- [Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients](https://scholariq.org/papers/liver-fibrosis-progression-in-human-immunodeficiency-virus-and-hepatitis-c-virus/)
- [Liver fibrosis in overweight patients](https://scholariq.org/papers/liver-fibrosis-in-overweight-patients/)
- [Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C](https://scholariq.org/papers/rates-and-risk-factors-of-liver-fibrosis-progression-in-patients-with-chronic/)
- [High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses](https://scholariq.org/papers/high-prevalence-of-braf-v600e-mutations-in-erdheim-chester-disease-but-not-in/)
- [Extrahepatic manifestations of chronic hepatitis C](https://scholariq.org/papers/extrahepatic-manifestations-of-chronic-hepatitis-c/)
- [2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection](https://scholariq.org/papers/2016-comprehensive-update-of-the-banff-working-group-on-liver-allograft/)
- [Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease](https://scholariq.org/papers/consensus-recommendations-for-the-diagnosis-and-clinical-management-of-rosai/)
- [Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy](https://scholariq.org/papers/changes-in-aids-related-lymphoma-since-the-era-of-highly-active-antiretroviral/)
- [Identification of CD8 <sup>+</sup> CD25 <sup>+</sup> Foxp3 <sup>+</sup> suppressive T cells in colorectal cancer tissue](https://scholariq.org/papers/identification-of-cd8-sup-sup-cd25-sup-sup-foxp3-sup-sup-suppressive-t-cells-in/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [Sorbonne Université](https://scholariq.org/institutions/sorbonne-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.